H.C. Wainwright lowered the firm’s price target on Adicet Bio to $10 from $26 and keeps a Buy rating on the shares. The firm increased its estimate for the number of outstanding shares following the company’s capital raise.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ACET:
